Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,262,176
-$432,676 QoQ
Shares Held
52,416
-13.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#1,185
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Key Financial Inc holds $18,745,925 across 16 Drug Manufacturers - General names. PFE ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,096 | $6,373,630 | |
| 2 | ABBV |
AbbVie Inc.
|
16,434 | $4,135,451 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,676 | $2,913,866 | |
| 4 | PFE |
Pfizer Inc
This page
|
52,416 | $1,262,176 | |
| 5 | LLY |
ELI LILLY & Co
|
824 | $988,330 | |
| 6 | AZN |
Astrazeneca PLC
|
4,187 | $793,938 | |
| 7 | AMGN |
Amgen Inc
|
1,527 | $552,957 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,257 | $537,829 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,262,176 | 52,416 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,694,852 | 60,358 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,519,596 | 61,028 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,617,470 | 63,480 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,561,564 | 64,421 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,711,362 | 67,536 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,831,127 | 69,021 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,084,200 | 72,018 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,028,410 | 72,495 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,031,466 | 73,206 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,104,318 | 73,092 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,540,954 | 76,604 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,862,140 | 78,030 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $3,202,759 | 78,499 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,900,901 | 76,130 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $3,331,448 | 76,130 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $2,169,081 | 41,371 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,103,415 | 40,630 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,069,171 | 35,041 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,503,672 | 34,961 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,298,584 | 33,161 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,358,335 | 37,492 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,199,159 | 32,577 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,365,201 | 37,199 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,070,370 | 32,733 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,252,068 | 38,360 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||